Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain

Jose-María Abellán-Perpiñán et al.

European Journal of Health Economics2026https://doi.org/10.1007/s10198-026-01894-8article
AJG 2ABDC A
Weight
0.50

Abstract

This analysis showed that vaccinating older adults in Spain with HD-QIV instead of SD-QIV would reduce cases of influenza, GP and ED visits, hospitalizations, deaths, and associated costs, and thus it should be the strategy of choice in a situation of budgetary constraints from either a societal or an NHS perspective.

Open via your library →

Cite this paper

https://doi.org/https://doi.org/10.1007/s10198-026-01894-8

Or copy a formatted citation

@article{jose-maría2026,
  title        = {{Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain}},
  author       = {Jose-María Abellán-Perpiñán et al.},
  journal      = {European Journal of Health Economics},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1007/s10198-026-01894-8},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain

Flags are reviewed by the Arbiter methodology team within 5 business days.


Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.